Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Dr Frost.

Photo of Joe Frost

After completing his undergraduate degree in Natural Sciences at the University of Cambridge, Joe Frost was awarded joint funding by the RDM Scholars Programme and the Christopher Welch Scholarship in Biological Sciences to conduct a D.Phil., with Professor Hal Drakesmith.

His research in the Drakesmith lab asks how iron availability impacts upon immunity. Genetic defects in immune cell iron uptake have been found to cause a human immunodeficiency syndrome, demonstrating the adaptive immune system's requirement for iron. He hypothesised that iron may become limiting for lymphocytes under conditions of physiological iron deficiency, resulting in an impaired adaptive immune response. Iron deficiency is the most prevalent micronutrient deficiency worldwide; understanding the nutritional requirements of immune responses might help us better implement vaccination regimes.

Find out more about his work. 

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Spin-out company Alethiomics launches

The enterprise will focus on developing targeted therapies for a specific family of blood cancers.

Iron integral to the development of life on Earth – and the possibility of life on other planets

A collaboration between researchers at the MRC WIMM/RDM and Department of Earth Sciences uncovers the importance of iron for the development of complex life on Earth.

Strong cytotoxic T cell responses to an internal viral component are associated with mild COVID-19 disease

Study from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.